Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec 15;208(12):1345-1346.
doi: 10.1164/rccm.202309-1671LE.

A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists

Qiumeng Li  1 , Yating Chen  1 , Hang Jiang  1 , Yue Xi  1 , Jiahe Wang  1 , Xiaofeng Zhu  1 , Jianxiong Lai  1 , Nuofu Zhang  1 , Dongxing Zhao  1
Affiliations
Comment

A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists

Qiumeng Li et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Li et al.
    Foer D, Strasser ZH, Cui J, Cahill KN, Boyce JA, Murphy SN, Karlson EW. Foer D, et al. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1346-1347. doi: 10.1164/rccm.202310-1721LE. Am J Respir Crit Care Med. 2023. PMID: 37855723 Free PMC article. No abstract available.

Comment on

References

    1. Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG. Targeting mechanisms linking COPD to type 2 diabetes mellitus. Trends Pharmacol Sci . 2017;38:940–951. - PubMed
    1. Huang J, Yi H, Zhao C, Zhang Y, Zhu L, Liu B, et al. Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients. Int J Chron Obstruct Pulmon Dis . 2018;13:3191–3202. - PMC - PubMed
    1. Huang J. Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients [abstract] Am J Respir Crit Care Med . 2019;199:A4525. - PMC - PubMed
    1. Foer D, Strasser ZH, Cui J, Cahill KN, Boyce JA, Murphy SN, et al. Association of GLP-1 receptor agonists with COPD exacerbations among patients with type 2 diabetes. Am J Respir Crit Care Med . 2023;208:1088–1100. - PMC - PubMed
    1. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med . 1998;128:165–175. - PubMed

MeSH terms

Substances